Regenxbio (RGNX) Other Non-Current Liabilities (2018 - 2025)

Regenxbio's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $638000.0 for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities fell 82.45% year-over-year to $638000.0; the TTM figure through Dec 2025 stood at $638000.0 (down 82.45% YoY), while the FY2025 annual figure was $638000.0, down 82.45% from the prior year.
• Other Non-Current Liabilities was $638000.0 for Q4 2025 at Regenxbio, down from $648000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $171.3 million in Q4 2021 to a low of $448000.0 in Q1 2021.
• Historically, Other Non-Current Liabilities has averaged $47.4 million across 5 years, with a median of $21.8 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities surged 27246.88% in 2022, then slumped 98.48% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $171.3 million in 2021, then dropped by 19.69% to $137.6 million in 2022, then sank by 68.4% to $43.5 million in 2023, then tumbled by 91.64% to $3.6 million in 2024, then sank by 82.45% to $638000.0 in 2025.
• The last three Other Non-Current Liabilities figures came in at $638000.0 (Q4 2025), $648000.0 (Q3 2025), and $664000.0 (Q2 2025), per Business Quant data.